Coreg CR Opens New Opportunity In Hypertension, GSK’s Stout Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The once-daily formulation of carvedilol will make it a more attractive option for hypertension than the previous Coreg.
You may also be interested in...
Generic Coreg To Launch Immediately Following FDA Approval
Several generic drug makers received ANDA approval for generic versions of GlaxoSmithKline’s blockbuster heart failure medication.
Generic Coreg To Launch Immediately Following FDA Approval
Several generic drug makers received ANDA approval for generic versions of GlaxoSmithKline’s blockbuster heart failure medication.
Coreg CR Approved; GSK Plans First Quarter 2007 Launch
Micropump technology licensed from French drug delivery firm Flamel modulates release of GSK’s carvedilol over 24 hours.